First human tests: drug company checks safety of new compound in chinese volunteers
NCT ID NCT07024797
Summary
This early-stage study tested how a new oral compound called ABBV-932 moves through the body and checked for side effects. It involved 20 healthy Chinese adult volunteers to gather basic safety and dosing information. The main goal was to understand how the body processes the drug at different dose levels.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Shanghai Mental Health Center /ID# 273427
Shanghai, Shanghai Municipality, 200030, China
Conditions
Explore the condition pages connected to this study.